½ÃÀ庸°í¼­
»óǰÄÚµå
1711586

3D ´Ü¹éÁú ±¸Á¶ ºÐ¼® ½ÃÀå - ¼¼°è ¹× Áö¿ªº° ºÐ¼® : Á¦Ç°º°, ¿ëµµº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº° - ºÐ¼®°ú ¿¹Ãø(2025-2035³â)

3D Protein Structure Analysis Market - A Global and Regional Analysis: Focus on Product, End User, and Region - Analysis and Forecast, 2025-2035

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: BIS Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® | ¹è¼Û¾È³» : 1-5ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

¼¼°èÀÇ 3D ´Ü¹éÁú ±¸Á¶ ºÐ¼® ½ÃÀå ±Ô¸ð´Â 2025-2035³âÀÇ ¿¹Ãø ±â°£ Áß 9%ÀÇ CAGR·Î È®´ëÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼¼°è 3D ´Ü¹éÁú ±¸Á¶ ºÐ¼® ½ÃÀåÀÇ ¼ºÀåÀº ´Ü¹éÁú ±¸Á¶ ºÐ¼®¿ë ÀåºñÀÇ ±â¼ú ¹ßÀü°ú ´Ü¹éÁú ±¸Á¶ ºÐ¼®À» °¡¼ÓÈ­Çϱâ À§ÇÑ ¿¬±¸°³¹ßºñ¿ë Áõ°¡¿¡ ÀÇÇØ ÁÖµµµÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ºÐÀÚ»ý¹°ÇÐ ¿¬±¸ÀÇ ÁÖ¿ä ¸ñÇ¥ Áß Çϳª´Â ´Ü¹éÁú ±¸Á¶¸¦ ÀÌÇØÇÏ´Â °ÍÀÔ´Ï´Ù. ´Ü¹éÁú º¹ÇÕü ºÐ¼®Àº ´Ü¹éÁúÀÌ º¹ÀâÇÑ »ý¹°ÇÐÀû »ùÇÿ¡ Æ÷ÇԵǾî ÀÖÀ¸¹Ç·Î ´Ü¹éÁúÀÇ ±¸Á¶¿Í ±â´ÉÀ» ¿ÏÀüÈ÷ Æò°¡ÇÏ´Â °ÍÀ» Æ÷ÇÔÇÕ´Ï´Ù. ´Ü¹éÁú º¹ÇÕüÀÇ ±¸Á¶´Â Çö´ëÀÇ ´Ü¹éÁú º¹ÇÕü ºÐ¼®¹ýÀ» »ç¿ëÇÏ¿© ¹ß°ßÇÒ ¼ö ÀÖ½À´Ï´Ù. ÇöÀç ±ØÀú¿Â ÀüÀÚÇö¹Ì°æ(EM), X¼± ¼Ò°¢ »ê¶õ(SAXS), ÇÙÀڱ⠰ø¸í(NMR) ºÐ±¤¹ý, X¼± °áÁ¤ ±¸Á¶ ºÐ¼®Àº ºÐÀÚ ±¸Á¶¿Í ºÐÀÚ ÀÎ½Ä ¸ÞÄ¿´ÏÁòÀ» ±â¼úÇϰí ÀÌÇØÇϱâ À§ÇÑ ³ë·Â¿¡ ±¤¹üÀ§ÇÏ°Ô »ç¿ëµÇ°í ÀÖÀ¸¸ç, Bruker Corporation, JEOL Ltd. µîÀÇ ÁÖ¿ä ¾÷üµéÀº Çʿ信 µû¶ó 3D ´Ü¹éÁú ±¸Á¶ºÐ¼®À» À§ÇÑ Àåºñ¸¦ Á¦°øÇÕ´Ï´Ù. ÀÌ·¯ÇÑ Àåºñ´Â ½ÇÇè½ÇÀÇ Ã³¸®·® ¿ä±¸¸¦ ÃæÁ·½Ãų ¼ö ÀÖ½À´Ï´Ù.

  • 3D ´Ü¹éÁú ±¸Á¶ ºÐ¼®ÀÇ ÁÖ¿ä Àåºñ °ø±ÞÀÚÀÇ Á¸Àç´Â ½ÃÀå¿¡ Å« ¿µÇâÀ» ¹ÌÄ¡°í ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î 2022³â 4¿ù NJ Biopharmaceuticals LLC¿Í JEOL Ltd.´Â JEOLÀÇ 800 MHz NMRÀ» ÀÌ¿ëÇÑ Çõ½ÅÀûÀÎ ½Å¾à°³¹ß Ç÷§Æû ¼Ö·ç¼ÇÀ» Á¦°øÇϱâ À§ÇÑ Á¦ÈÞ¸¦ ¹ßÇ¥Çß½À´Ï´Ù. À̹ø Á¦ÈÞ¸¦ ÅëÇØ JEOLÀº 3D ´Ü¹éÁú ±¸Á¶ ºÐ¼®ÀÇ ±â¹ÝÀ» È®ÀåÇÏ°í ±âÁ¸ Á¦Ç° ¶óÀξ÷À» ´Ã¸®´Â °ÍÀ» ¸ñÇ¥·Î Çϰí ÀÖ½À´Ï´Ù.
  • 2020³â 8¿ù, ¼¼°èÀûÀÎ °úÇÐ ¼­ºñ½º ±â¾÷ Thermo Fisher Scientific Inc.´Â Á¦¾à ¹× »ý¸í°øÇÐ ±â¾÷°ú ÀÌ È¹±âÀûÀÎ ±â¼úÀÇ ½ºÅ¸Æ®¾÷ ÆÐŰÁö¸¦ ¼­ºñ½ºÇÏ´Â CRO(Contract Research Organization)¸¦ ¿¬°áÇÏ¿© ±ØÀú¿Â ÀüÀÚÇö¹Ì°æ(CryoEM)¿¡ ´ëÇÑ Á¢±ÙÀ» ¿ëÀÌÇÏ°Ô ÇÑ´Ù°í ¹ßÇ¥Çß½À´Ï´Ù. Çö¹Ì°æ(cryoEM)¿¡ ´ëÇÑ Á¢±ÙÀ» ¿ëÀÌÇÏ°Ô ÇÒ °ÍÀ̶ó°í ¹ßÇ¥Çß½À´Ï´Ù.
  • 3D ´Ü¹éÁú ±¸Á¶ ºÐ¼® ½ÃÀå ¼¼ºÐÈ­:

Á¦Ç°º°·Î´Â ¼¼°è 3D ´Ü¹éÁú ±¸Á¶ ºÐ¼® ½ÃÀåÀº ¼Ò¸ðǰ ºÎ¹®ÀÌ Áö¹èÀûÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ´Â 3D ´Ü¹éÁú ±¸Á¶ ºÐ¼®ÀÇ ´Ù¾çÇÑ ±â¼ú¿¡ »ç¿ëµÇ´Â ¿©·¯ ½Ã¾à, ŰƮ, ½ºÅ©¸°, ¿ë¸Å, ¼¼Á¤Á¦ µîÀ» »ç¿ëÇÒ ¼ö Àֱ⠶§¹®ÀÔ´Ï´Ù.

¿ëµµº°·Î´Â ÀÓ»ó Áø´Ü ºÐ¾ß°¡ Àü ¼¼°è 3D ´Ü¹éÁú ±¸Á¶ ºÐ¼® ½ÃÀå¿¡¼­ °¡Àå Å« ºñÁßÀ» Â÷ÁöÇϰí ÀÖ½À´Ï´Ù. Áúº´ Áõ°¡°¡ ÀÌ ºÎ¹® ½ÃÀå ¼ºÀåÀ» ÁÖµµÇϰí ÀÖ½À´Ï´Ù.

ÃÖÁ¾»ç¿ëÀÚº°·Î´Â ¹ÙÀÌ¿À Á¦¾àȸ»ç°¡ ¼¼°è 3D ´Ü¹éÁú ±¸Á¶ ºÐ¼® ½ÃÀåÀ» µ¶Á¡Çϰí ÀÖ½À´Ï´Ù. ÀǾàǰ °³¹ßÀ» À§ÇÑ Á¦¾àȸ»ç¸¦ Áß½ÉÀ¸·Î ´Ù¾çÇÑ »ê¾÷¿¡¼­ ´Ü¹éÁú ±¸Á¶ ºÐ¼®ÀÇ È°¿ëÀÌ È®´ëµÇ°í ÀÖ´Â °ÍÀÌ ÀÌ ½ÃÀåÀÇ µ¿Çâ È®´ë¿¡ ´õ¿í ±â¿©ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¼¼°è 3D ´Ü¹éÁú ±¸Á¶ ºÐ¼® ½ÃÀåÀÇ ÃÖ±Ù µ¿Çâ

  • 2022³â 2¿ù, JEOLÀº ´Ü¹éÁú ´ÜÀÔÀÚ ºÐ¼®¿¡ ƯȭµÈ ½ÅÇü ³ÃÀ½±Ø ÀüÀÚÇö¹Ì°æ(±ØÀú¿Â ÀüÀÚÇö¹Ì°æ) 'CRYO ARM 200 II'(JEM-Z200CA)¸¦ °³¹ßÇß´Ù°í ¹ßÇ¥Çß½À´Ï´Ù.
  • 2021³â 11¿ù, ´ÏÈ¥ÀüÀÚ´Â ÇÙÀÚ±â°ø¸íÀåºñ 'ECZ Luminous'(JNM-ECZL ½Ã¸®Áî)ÀÇ Ãâ½Ã¸¦ ¹ßÇ¥Çß½À´Ï´Ù. ÀÌ Á¦Ç°Àº ÃÖ÷´Ü µðÁöÅÐ ±â¼ú°ú °íÁÖÆÄ ±â¼úÀ» ÅëÇØ ºÐ±¤±âÀÇ ¼ÒÇüÈ­¿Í ¼º´É Çâ»óÀ» ½ÇÇöÇÑ ´ÙÀ½ ´Ü°èÀÇ Á¦Ç°ÀÔ´Ï´Ù.
  • 2020³â 10¿ù, Thermo Fisher Scientific Inc.´Â µÎ °¡Áö ȹ±âÀûÀÎ À̹Ì¡ ÇÊÅÍ, Áï Thermo Scientific Selectris Imaging Filter¿Í Thermo Scientific Selectris X Imaging Filter¸¦ Ãâ½ÃÇß½À´Ï´Ù. Imaging Filter¸¦ Ãâ½ÃÇÏ¿© »ç¿ëÀÚ°¡ ÁøÁ¤ÇÑ ¿øÀÚ ÇØ»óµµ·Î ´Ü¹éÁúÀ» °üÂûÇÒ ¼ö ÀÖ°Ô ÇÔÀ¸·Î½á ±ØÀú¿Â ÀüÀÚÇö¹Ì°æ(±ØÀú¿Â ÀüÀÚÇö¹Ì°æ)À» »õ·Î¿î Â÷¿øÀ¸·Î ²ø¾î¿Ã·È½À´Ï´Ù.
  • 2021³â 4¿ù, Thermo Fisher Scientific Inc.´Â Thermo Scientific Krios Cryo-TEM°ú »õ·Î¿î ³ÃÀü°è ¹æÃâ ÃÑÀÇ Áß¿äÇÑ ¾×¼¼¼­¸®ÀÎ Thermo Scientific E-CFEG¸¦ ¹ßÇ¥Çß½À´Ï´Ù. ´Ù¸¥ »ó¿ë ±â¼ú°ú ºñ±³ÇÏ¿© E-four CFEGÀÇ ÁÖ¿ä ±¸¼º ¿ä¼Ò´Â Àü·Ê¾ø´Â ´ÜÀÏ ÀÔÀÚ ºÐ¼®(SPA) ºÐÇØ´É ¼öÁØÀ» ´Þ¼ºÇϱâ À§ÇØ Çù·ÂÇÕ´Ï´Ù.

Á¦Ç°/Çõ½Å Àü·«: ÀÌ º¸°í¼­¿¡¼­´Â ¼Ò¸ðǰ, Àåºñ, °è»ê ¼ÒÇÁÆ®¿þ¾î¸¦ ±â¹ÝÀ¸·Î ÇÏ´Â ±â¾÷À» »ìÆìº¾´Ï´Ù. ´ëºÎºÐÀÇ ±â¾÷Àº 3D ´Ü¹éÁú ±¸Á¶ ºÐ¼®À» À§ÇÑ Àåºñ¿Í ȣȯµÇ´Â ¼Ò¸ðǰÀ» Á¦°øÇÕ´Ï´Ù.

¼ºÀå/¸¶ÄÉÆÃ Àü·«: 3D ´Ü¹éÁú ±¸Á¶ ºÐ¼®ÀÇ ÁÖ¿ä ±¸¼º ¿ä¼Ò´Â Àåºñ, ¼Ò¸ðǰ, °è»ê ¼ÒÇÁÆ®¿þ¾îÀÔ´Ï´Ù. ÁÖ¿ä ½ÃÀå ¸ÅÃâÀº ¼Ò¸ðǰ ºÎ¹®¿¡¼­ âÃâµË´Ï´Ù. Àüü ¿öÅ©Ç÷ο쿡 ´ëÇØ´Â »ý»ê¿¡ °ü¿©ÇÏ´Â ÁÖ¿ä ¾÷ü¸¦ °í·ÁÇÑ °¡°Ý ºÐ¼®°ú ÇÔ²² ÀÌ º¸°í¼­¿¡¼­ ÃæºÐÈ÷ ¼³¸íµÇ¾î ÀÖ½À´Ï´Ù.

°æÀï Àü·«: ¼¼°è 3D ´Ü¹éÁú ±¸Á¶ ºÐ¼® ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷Àº ¼Ò¸ðǰ, Àåºñ, °è»ê ¼ÒÇÁÆ®¿þ¾î ±â¹Ý ±â¾÷À¸·Î ±¸¼ºµÇ¾î ÀÖÀ¸¸ç, ÀÌ º¸°í¼­¿¡¼­ ºÐ¼® ¹× ÇÁ·ÎÆÄÀϸµµÇ¾ú½À´Ï´Ù. ¶ÇÇÑ ¼¼°è 3D ´Ü¹éÁú ±¸Á¶ ºÐ¼® ½ÃÀå¿¡¼­ Ȱµ¿ÇÏ´Â Âü°¡ÀÚµéÀÇ »ó¼¼ÇÑ °æÀï º¥Ä¡¸¶Å·Àº µ¶Àڵ鿡°Ô ¸íÈ®ÇÑ ½ÃÀå »óȲÀ» Á¦½ÃÇϰí Âü°¡ÀÚµéÀÌ ¼­·Î ¾î¶»°Ô ¼­·Î °ãÄ¡´ÂÁö ÀÌÇØÇÏ´Â µ¥ µµ¿òÀÌ µÉ °ÍÀÔ´Ï´Ù. ¶ÇÇÑ ÆÄÆ®³Ê½Ê, ÇùÁ¤, Çù·Â°ú °°Àº Á¾ÇÕÀûÀÎ °æÀï Àü·«Àº µ¶ÀÚµéÀÌ ½ÃÀåÀÇ ¹Ì°³¹ß ¸ÅÃâ Æ÷ÄÏÀ» ÀÌÇØÇÏ´Â µ¥ µµ¿òÀÌ µÉ °ÍÀÔ´Ï´Ù.

¼¼°èÀÇ 3D ´Ü¹éÁú ±¸Á¶ ºÐ¼® ½ÃÀå¿¡ ´ëÇØ Á¶»çÇßÀ¸¸ç, ½ÃÀåÀÇ °³¿ä¿Í Á¦Ç°º°, ¿ëµµº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº° µ¿Çâ ¹× ½ÃÀå¿¡ Âü¿©ÇÏ´Â ±â¾÷ÀÇ °³¿ä µîÀ» Á¦°øÇϰí ÀÖ½À´Ï´Ù.

¸ñÂ÷

°³¿ä

Á¦1Àå ¾÷°è Àü¸Á

  • ½ÃÀå °³¿ä
  • ƯÇ㠺м®
    • ƯÇã Ãâ¿ø µ¿Çâ
  • ±ÔÁ¦ »óȲ
  • ÁÖ¿ä µ¿Çâ

Á¦2Àå ½ÃÀå ¿ªÇÐ

  • °³¿ä
    • ¿µÇ⠺м®
  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
  • ½ÃÀå ±âȸ

Á¦3Àå ¼¼°èÀÇ 3D ´Ü¹éÁú ±¸Á¶ ºÐ¼® ½ÃÀå : °æÀï ±¸µµ

  • °³¿ä
  • ±â¾÷ Àü·«
  • ºñÁî´Ï½º Àü·«
  • »óȯ ½Ã³ª¸®¿À

Á¦4Àå ¼¼°èÀÇ 3D ´Ü¹éÁú ±¸Á¶ ºÐ¼® ½ÃÀå, Á¦Ç°º°, (100¸¸ ´Þ·¯), 2023-2035³â

  • °³¿ä
  • ¼Ò¸ðǰ
  • Àåºñ
  • °è»ê ¼ÒÇÁÆ®¿þ¾î

Á¦5Àå ¼¼°èÀÇ 3D ´Ü¹éÁú ±¸Á¶ ºÐ¼® ½ÃÀå, ¿ëµµº°, (100¸¸ ´Þ·¯), 2023-2035³â

  • °³¿ä
  • ÀÓ»ó Áø´Ü
  • Drug Discovery
  • ±âŸ

Á¦6Àå ¼¼°èÀÇ 3D ´Ü¹éÁú ±¸Á¶ ºÐ¼® ½ÃÀå, ÃÖÁ¾»ç¿ëÀÚº°, (100¸¸ ´Þ·¯), 2023-2035³â

  • °³¿ä
  • ¹ÙÀÌ¿ÀÀǾàǰ ȸ»ç
  • Çмú¿¬±¸±â°ü
  • ±âŸ

Á¦7Àå ¼¼°èÀÇ 3D ´Ü¹éÁú ±¸Á¶ ºÐ¼® ½ÃÀå, Áö¿ªº°, (100¸¸ ´Þ·¯), 2023-2035³â

  • °³¿ä
  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
  • À¯·´
    • µ¶ÀÏ
    • ¿µ±¹
    • ÇÁ¶û½º
    • ÀÌÅ»¸®¾Æ
    • ½ºÆäÀÎ
    • ±âŸ
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • Áß±¹
    • ÀϺ»
    • Àεµ
    • Çѱ¹
    • È£ÁÖ
    • ±âŸ
  • ±âŸ Áö¿ª

Á¦8Àå ±â¾÷ °³¿ä

  • Bruker Corporation
  • JEOL Ltd.
  • Spectris plc
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Schrodinger, Inc.
  • Molecular Dimensions
  • Arinax Scientific Instrumentation
  • Cambridge Isotope Laboratories, Inc.
  • HAMPTON RESEARCH CORP.
  • DNASTAR
  • RosettaCommons.org
  • Rigaku Corporation
  • Dassault Systemes
  • Jena Bioscience GmbH
KSA 25.05.08

Global 3D Protein Structure Analysis Market Overview

The global 3D protein structure analysis market is expected to grow at a CAGR of 9% during the forecast period from 2025 to 2035. The growth in the global 3D protein structure analysis market is expected to be driven by technological advancements in equipment for protein structure analysis and by an increase in R&D expenditure to accelerate protein structure analysis.

Market Lifecycle Stage

One of the main goals of molecular biology research is to understand protein structure. Protein complex analysis involves a complete evaluation of the structure and function of proteins because proteins are found in intricate biological samples. The structure of protein complexes can be discovered using contemporary protein complex analysis methods. At present cryo-electron microscopy (EM), small angle X-Ray scattering (SAXS), nuclear magnetic resonance (NMR) spectroscopy, and X-Ray crystallography are used extensively in efforts to describe and understand molecular structures and molecular recognition mechanisms. Leading manufacturers like Bruker Corporation, JEOL Ltd., and Spectris plc provide equipment for 3D protein structure analysis according to one's needs. These equipment can address the laboratory's throughput needs.

Impact

  • The presence of major equipment providers of 3D protein structure analysis has a major impact on the market. For instance, in April 2022, NJ Biopharmaceuticals LLC and JEOL Ltd. announced their collaboration to bring innovative drug discovery platform solutions using JEOL's 800 MHz NMR. With the help of this partnership, JEOL Ltd. aspires to grow its 3D protein structure analysis base and increase its existing product line.
  • In August 2020, Thermo Fisher Scientific Inc., a global player in providing scientific services, announced that it would facilitate access to cryo-electron microscopy (cryo-EM) by connecting pharmaceutical and biotechnology companies with contract research organizations (CROs) that provide start-up packages for this game-changing technology as a service.
  • 3D Protein Structure Analysis Market Segmentation:

Segmentation 1: by Product

  • Consumable
  • Equipment
  • Computational Software

Based on product, the global 3D protein structure analysis market is expected to be dominated by the consumable segment. This is due to the availability of several reagents, kits, screens, solvents, detergents, and others to be used in different technologies for 3D protein structure analysis.

Segmentation 2: by Application

  • Clinical Diagnosis
  • Drug Discovery
  • Other Application

Based on application, the clinical diagnosis segment accounted for the largest share of global 3D protein structure analysis market. The increasing incidences of diseases will drive the market growth of this segment.

Segmentation 3: by End User

  • Biopharmaceutical Company
  • Academic and Research Institute
  • Other End User (CRO, CDMOs, Research Hospitals, R&D Centers, etc.)

Based on end users, the biopharmaceutical company segment is the dominating end user in the global 3D protein structure analysis market. The expanding application of protein structure analysis in a variety of industries, primarily in pharmaceutical companies for drug development, is further expected to contribute to its growing trend.

Segmentation 4: by Region

  • North America
  • Europe
  • Asia-Pacific
  • Rest-of-the-World

Recent Developments in Global 3D Protein Structure Analysis Market

  • In February 2022, JEOL Ltd. announced the development of a new cold field emission cryo-electron microscope (cryo-EM), the CRYO ARM 200 II (JEM-Z200CA), dedicated to single particle analysis of proteins.
  • In November 2021, JEOL Ltd. announced the availability of "ECZ Luminous" nuclear magnetic resonance console (JNM-ECZL series). This product is the next step in spectrometer miniaturization and extended performance through state-of-the-art digital and high-frequency technologies.
  • In October 2020, Thermo Fisher Scientific Inc. introduced two ground-breaking imaging filters, i.e., the Thermo Scientific Selectris Imaging Filter and the Thermo Scientific Selectris X Imaging Filter, which elevated cryo-electron microscopy (cryo-EM) to a new level by allowing users to view proteins at true atomic resolution.
  • In April 2021, Thermo Fisher Scientific Inc. unveiled the Thermo Scientific E-CFEG, a significant accessory for the Thermo Scientific Krios Cryo-TEM and the company's new cold field emission gun. In comparison to other commercially available technologies, the E-four CFEG's key components work together to achieve single particle analysis (SPA) resolution levels that are unprecedented.

Demand - Drivers and Limitations

Following are the demand drivers for the global 3D protein structure analysis market:

  • Technological advancements in equipment for protein structure analysis
  • Increase in R&D expenditure to accelerate protein structure analysis
  • Rising focus on miniaturization

The 3D protein structure analysis market is expected to face some limitations too due to the following challenges:

  • Certain instrument limitations pertaining to 3D protein structure analysis
  • Lack of qualified personnel
  • High cost and time-consuming method

How can this report add value to an organization?

Product/Innovation Strategy: The report considers consumable, equipment, and computational software-based companies. Most companies provide consumables that are compatible with equipment for 3D protein structure analysis.

Growth/Marketing Strategy: The key components in 3D protein structure analysis are the equipment, consumable, and computational software. The main market revenue is generated from the consumable segment. The entire workflow has been well explained in the report, along with pricing analysis considering the key companies involved in the production.

Competitive Strategy: The key players in the global 3D protein structure analysis market have been analyzed and profiled in the study, consisting of consumable, equipment, and computational software-based companies. Moreover, a detailed competitive benchmarking of the players operating in the global 3D protein structure analysis market has been done to help the reader understand how players stack against each other, presenting a clear market landscape. Additionally, comprehensive competitive strategies such as partnerships, agreements, and collaborations will aid the reader in understanding the untapped revenue pockets in the market.

Key Market Players and Competition Synopsis of 3D Protein Structure Analysis

The companies that are profiled have been selected based on inputs gathered from primary experts, analyzing company coverage, product portfolio, and market penetration.

Some of the prominent names established in 3D protein structure analysis market are:

  • Merck KGaA
  • Molecular Dimensions
  • Cambridge Isotope Laboratories, Inc.
  • HAMPTON RESEARCH CORP.
  • Jena Bioscience GmbH
  • Bruker Corporation
  • JEOL Ltd.
  • Spectris plc
  • Thermo Fisher Scientific, Inc.
  • Arinax Scientific Instrumentation.
  • Rigaku Corporation
  • Schrodinger, Inc.
  • DNASTAR
  • RosettaCommons.org
  • Dassault Systemes

Table of Contents

Executive Summary

Scope and Definition

Market/Product Definition

Inclusion and Exclusion

Key Questions Answered

Research Methodology

1. Industry Outlook

  • 1.1 Market Overview
  • 1.2 Patent Analysis
    • 1.2.1 Patent Filing Trend
  • 1.3 Regulatory Landscape
  • 1.4 Key Trends

2. Market Dynamics

  • 2.1 Overview
    • 2.1.1 Impact Analysis
  • 2.2 Market Drivers
  • 2.3 Market Restraints
  • 2.4 Market Opportunities

3. Global 3D Protein Structure Analysis Market: Competitive Landscape

  • 3.1 Overview
  • 3.2 Corporate Strategies
    • 3.2.1 Mergers and Acquisitions
    • 3.2.2 Synergistic Activities
    • 3.2.3 Business Expansions and Funding
  • 3.3 Business Strategies
    • 3.3.1 Product Launches and Approvals
    • 3.3.2 Publications
    • 3.3.3 Licenses and Agreements
    • 3.3.4 Other Activities
  • 3.4 Reimbursement Scenario.

4. Global 3D Protein Structure Analysis Market (by Product), ($Million), 2023-2035

  • 4.1 Overview
  • 4.2 Consumable
    • 4.2.1 X-Ray Crystallography
    • 4.2.2 Nuclear Magnetic Resonance (NMR) Spectroscopy
    • 4.2.3 Cryo-Electron Microscopy (Cryo-EM)
    • 4.2.4 Small Angle X-Ray Scattering (SAXS)
  • 4.3 Equipment
    • 4.3.1 X-Ray Crystallography
    • 4.3.2 Nuclear Magnetic Resonance (NMR) Spectroscopy
    • 4.3.3 Cryo-Electron Microscopy (Cryo-EM)
    • 4.3.4 Small Angle X-Ray Scattering (SAXS)
  • 4.4 Computational Software

5. Global 3D Protein Structure Analysis Market (by Application), ($Million), 2023-2035

  • 5.1 Overview
  • 5.2 Clinical Diagnosis
  • 5.3 Drug Discovery
  • 5.4 Other Application

6. Global 3D Protein Structure Analysis Market (by End User), ($Million), 2023-2035

  • 6.1 Overview
  • 6.2 Biopharmaceutical Company
  • 6.3 Academic and Research Institute
  • 6.4 Other End User

7. Global 3D Protein Structure Analysis Market (Region), ($Million), 2023-2035

  • 7.1 Overview
  • 7.2 North America
    • 7.2.1 U.S.
    • 7.2.2 Canada
  • 7.3 Europe
    • 7.3.1 Germany
    • 7.3.2 U.K.
    • 7.3.3 France
    • 7.3.4 Italy
    • 7.3.5 Spain
    • 7.3.6 Rest-of-Europe
  • 7.4 Asia Pacific
    • 7.4.1 China
    • 7.4.2 Japan
    • 7.4.3 India
    • 7.4.4 South Korea
    • 7.4.5 Australia
    • 7.4.6 Rest-of- Asia Pacific
  • 7.5 Rest-of-the-World

8. Company Profiles

  • 8.1 Overview
  • 8.2 Bruker Corporation
    • 8.2.1 Overview
    • 8.2.2 Top Products / Product Portfolio
    • 8.2.3 Top Competitors
    • 8.2.4 Target Customers/End-Users
    • 8.2.5 Key Personnel
    • 8.2.6 Analyst View
  • 8.3 JEOL Ltd.
    • 8.3.1 Overview
    • 8.3.2 Top Products / Product Portfolio
    • 8.3.3 Top Competitors
    • 8.3.4 Target Customers/End-Users
    • 8.3.5 Key Personnel
    • 8.3.6 Analyst View
  • 8.4 Spectris plc
    • 8.4.1 Overview
    • 8.4.2 Top Products / Product Portfolio
    • 8.4.3 Top Competitors
    • 8.4.4 Target Customers/End-Users
    • 8.4.5 Key Personnel
    • 8.4.6 Analyst View
  • 8.5 Thermo Fisher Scientific Inc.
    • 8.5.1 Overview
    • 8.5.2 Top Products / Product Portfolio
    • 8.5.3 Top Competitors
    • 8.5.4 Target Customers/End-Users
    • 8.5.5 Key Personnel
    • 8.5.6 Analyst View
  • 8.6 Merck KGaA
    • 8.6.1 Overview
    • 8.6.2 Top Products / Product Portfolio
    • 8.6.3 Top Competitors
    • 8.6.4 Target Customers/End-Users
    • 8.6.5 Key Personnel
    • 8.6.6 Analyst View
  • 8.7 Schrodinger, Inc.
    • 8.7.1 Overview
    • 8.7.2 Top Products / Product Portfolio
    • 8.7.3 Top Competitors
    • 8.7.4 Target Customers/End-Users
    • 8.7.5 Key Personnel
    • 8.7.6 Analyst View
  • 8.8 Molecular Dimensions
    • 8.8.1 Overview
    • 8.8.2 Top Products / Product Portfolio
    • 8.8.3 Top Competitors
    • 8.8.4 Target Customers/End-Users
    • 8.8.5 Key Personnel
    • 8.8.6 Analyst View
  • 8.9 Arinax Scientific Instrumentation
    • 8.9.1 Overview
    • 8.9.2 Top Products / Product Portfolio
    • 8.9.3 Top Competitors
    • 8.9.4 Target Customers/End-Users
    • 8.9.5 Key Personnel
    • 8.9.6 Analyst View
  • 8.10 Cambridge Isotope Laboratories, Inc.
    • 8.10.1 Overview
    • 8.10.2 Top Products / Product Portfolio
    • 8.10.3 Top Competitors
    • 8.10.4 Target Customers/End-Users
    • 8.10.5 Key Personnel
    • 8.10.6 Analyst View
  • 8.11 HAMPTON RESEARCH CORP.
    • 8.11.1 Overview
    • 8.11.2 Top Products / Product Portfolio
    • 8.11.3 Top Competitors
    • 8.11.4 Target Customers/End-Users
    • 8.11.5 Key Personnel
    • 8.11.6 Analyst View
  • 8.12 DNASTAR
    • 8.12.1 Overview
    • 8.12.2 Top Products / Product Portfolio
    • 8.12.3 Top Competitors
    • 8.12.4 Target Customers/End-Users
    • 8.12.5 Key Personnel
    • 8.12.6 Analyst View
  • 8.13 RosettaCommons.org
    • 8.13.1 Overview
    • 8.13.2 Top Products / Product Portfolio
    • 8.13.3 Top Competitors
    • 8.13.4 Target Customers/End-Users
    • 8.13.5 Key Personnel
    • 8.13.6 Analyst View
  • 8.14 Rigaku Corporation
    • 8.14.1 Overview
    • 8.14.2 Top Products / Product Portfolio
    • 8.14.3 Top Competitors
    • 8.14.4 Target Customers/End-Users
    • 8.14.5 Key Personnel
    • 8.14.6 Analyst View
  • 8.15 Dassault Systemes
    • 8.15.1 Overview
    • 8.15.2 Top Products / Product Portfolio
    • 8.15.3 Top Competitors
    • 8.15.4 Target Customers/End-Users
    • 8.15.5 Key Personnel
    • 8.15.6 Analyst View
  • 8.16 Jena Bioscience GmbH
    • 8.16.1 Overview
    • 8.16.2 Top Products / Product Portfolio
    • 8.16.3 Top Competitors
    • 8.16.4 Target Customers/End-Users
    • 8.16.5 Key Personnel
    • 8.16.6 Analyst View
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦